Roth Capital Remains Positive on Galena Biopharma (GALE) Following Zuplenz Launch

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. TMUS
7. SPY
8. CVS
9. UNH
10. AXP

Go back to Roth Capital Remains Positive on Galena Biopharma (GALE) Following Zuplenz Launch

Galena Biopharma (GALE) Announces U.S. Launch of Zuplenz

July 29, 2015 7:06 AM EDT

Galena Biopharma (NASDAQ: GALE) announced the product launch for Zuplenz (ondansetron) Oral Soluble Film in the United States.

Zuplenz is now available nationwide and is supplied in both 4 mg and 8 mg strengths. Zuplenz is clinically bioequivalent to ondansetron orally disintegrating tablets (ODT) with a safety profile equivalent to ondansetron. The novel, PharmFilm® oral soluble film technology utilized by Zuplenz provides for convenient delivery and several key patient benefits including:

Rapidly dissolves in the mouth in about 10 secondsEliminates the burden of swallowing pills... More